Universitätsklinikum Schleswig-Holstein (UKSH)

Repeated kidney re-transplantation—the Eurotransplant experience: a retrospective multicenter outcome analysis (2020) Assfalg V, Selig K, Tolksdorf J, Van Meel M, De Vries E, Ramsoebhag AM, Rahmel A, et al. Journal article Long-Term Follow-Up Guidelines and Organization of Long-Term Follow-Up Care for Childhood and Young Adult Cancer Survivors (2020) Langer T, Beck J, Stein A, Bokemeyer C, Gebauer J Authored book Sepsis and Autoimmune Disease: Pathology, Systems Medicine, and Artificial Intelligence (2020) Jendrek S, Lai X, Riemekasten G, Vera González J, Schmeck B, Bertrams W Book chapter / Article in edited volumes Sickle cell disease in Germany: Results from a national registry (2019) Kunz JB, Lobitz S, Grosse R, Oevermann L, Hakimeh D, Jarisch A, Cario H, et al. Journal article Human leucocyte antigen class i in hormone receptor-positive, HER2-negative breast cancer: Association with response and survival after neoadjuvant chemotherapy (2019) Sinn BV, Weber KE, Schmitt WD, Fasching P, Symmans WF, Blohmer JU, Karn T, et al. Journal article Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma (2019) Lopez C, Kleinheinz K, Aukema SM, Rohde M, Bernhart SH, Huebschmann D, Wagener R, et al. Journal article Indications for resection and perioperative outcomes of surgery for pancreatic neuroendocrine neoplasms in Germany: an analysis of the prospective DGAV StuDoQ vertical bar Pancreas registry (2019) Mintziras I, Keck T, Werner J, Fichtner-Feigl S, Wittel U, Senninger N, Vowinkel T, et al. Journal article CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum (2019) Konrad E, Nardini N, Caliebe A, Nagel I, Young D, Horvath G, Santoro SL, et al. Journal article Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study (2019) Heppt MV, Amaral T, Kähler KC, Heinzerling L, Hassel JC, Meissner M, Kreuzberg N, et al. Journal article A phase I dose escalation and expansion study of intratumorally administered CV8102 as a single-agent or in combination with anti-PD-1 antibodies in patients with advanced solid tumors (2019) Eigentler T, Krauss J, Schreiber J, Weishaupt C, Terheyden P, Heinzerling L, Mohr P, et al. Conference contribution